In this week’s View, Dr. Eagle looks at what adult cardiologists should know about congenital heart disease patients. He then discusses sudden cardiac arrest and death in competitive and recreational ...

Submissions for the CV Team and CV Pharmacists Poster Sessions at ACC.25, taking place March 29-31, 2025, in Chicago, IL, are now open. All members of the cardiovascular team are invited to submit ...

There's still time to join your colleagues at the Valentin Fuster Cardiovascular Symposium, taking place Dec. 6-8 in Washington, DC. Explore sessions like: Evolving Strategies of Antithrombotic ...

There are several companies that are not affiliated with the American College of Cardiology that are posting registration and housing information for ACC.24. To protect your information, please only ...

In this week’s View, Dr. Eagle looks at the use of waist-high compression tights in patients with postural orthostatic tachycardia syndrome (POTS). He then discusses a consensus statement on platelet ...

Time is running out to showcase your expertise! JACC: Case Reports is seeking standout cases that highlight the critical role of multi-modality imaging in the diagnosis or intervention of complex ...

Highlighted text has been updated as of December 20, 2024. The SURMOUNT-1 trial showed that among patients with obesity, once-weekly tirzepatide reduced body weight substantially as compared to ...

In this week’s View, Dr. Eagle looks at the 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis. He then discusses sex differences in ...

In this week’s View, Dr. Eagle looks at the potential role of genetics in predicting risk in people with aortic disease. He then compares plant and animal fat intake in overall cardiovascular disease ...

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane debate and discuss the outcomes of the trials presented on day 3 at ACC.24 including TARGET BP I (0:39), DEDICATE DZHK6 (3:07) and FULL ...

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane debate and discuss the outcomes of the trials presented on day 1 at ACC.24 including AEGIS II (0:45), VICTORION-INITATE (2:36), ...

Highlighted text has been updated as of December 23, 2024. The DanGer Shock trial showed that routine implantation of Impella CP on top of standard care is superior to standard care alone in reducing ...